- Conditions
- Atherosclerotic Lesions in the Aortorenal Ostium
- Interventions
- Express™ Renal Premounted Stent System
- Device
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2009
- U.S. locations
- 14
- States / cities
- Sarasota, Florida • Peoria, Illinois • Springfield, Illinois + 10 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 289–312
of 910
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Nephrolithotomy
- Interventions
- Standard Percutaneous nephrolithotomy
- Procedure
- Lead sponsor
- Duke University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 60 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2011
- U.S. locations
- 1
- States / cities
- Durham, North Carolina
- Conditions
- Coronary Artery Disease
- Interventions
- 3 months of dual antiplatelet therapy (DAPT), SYNERGY Stent System
- Drug · Device
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 2,009 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 89
- States / cities
- Phoenix, Arizona • Little Rock, Arkansas • Bakersfield, California + 75 more
- Conditions
- Coronary Artery Disease
- Interventions
- drug eluting coronary stent
- Device
- Lead sponsor
- Cook Group Incorporated
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 124 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2005
- U.S. locations
- 1
- States / cities
- Bloomington, Indiana
- Conditions
- Coronary Artery Disease
- Interventions
- TAXUS Liberté™-SR
- Device
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 247 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2010
- U.S. locations
- 18
- States / cities
- Little Rock, Arkansas • Sacramento, California • San Diego, California + 15 more
- Conditions
- Abdominal Aortic Aneurysms (AAA)
- Interventions
- Fenestrated TREO Stent Graft System
- Device
- Lead sponsor
- Bolton Medical
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2030
- U.S. locations
- 7
- States / cities
- Colorado Springs, Colorado • Tampa, Florida • Boston, Massachusetts + 4 more
- Conditions
- Hilar Cholangiocarcinoma
- Interventions
- Photodynamic therapy-Photofrin, Stenting procedure, Chemotherapy regimen
- Drug · Procedure
- Lead sponsor
- Concordia Laboratories Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2017
- U.S. locations
- 18
- States / cities
- Goodyear, Arizona • Scottsdale, Arizona • Los Angeles, California + 14 more
- Conditions
- Aortic Aneurysm, Abdominal
- Interventions
- Zenith® p-Branch® or Zenith® Fenestrated AAA Endovascular Graft
- Device
- Lead sponsor
- Cook Research Incorporated
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2023
- U.S. locations
- 2
- States / cities
- New York, New York
- Conditions
- Primary Open Angle Glaucoma
- Interventions
- XEN63 Glaucoma Treatment System
- Device
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 130 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2028
- U.S. locations
- 29
- States / cities
- Glendale, Arizona • Culver City, California • Petaluma, California + 25 more
- Conditions
- Primary Open-angle Glaucoma
- Interventions
- iStent supra, Cataract surgery
- Device · Procedure
- Lead sponsor
- Glaukos Corporation
- Industry
- Eligibility
- 45 Years and older
- Enrollment
- 505 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2020
- U.S. locations
- 1
- States / cities
- Racine, Wisconsin
- Conditions
- Coronary Arteriosclerosis, Acute Coronary Syndrome
- Interventions
- clopidogrel, placebo
- Drug
- Lead sponsor
- Accumetrics, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 2,800 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 72
- States / cities
- Birmingham, Alabama • Scottsdale, Arizona • La Jolla, California + 59 more
- Conditions
- Abdominal Aortic Aneurysm
- Interventions
- TriVascular Stent-Graft System
- Device
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 43 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2010
- U.S. locations
- 7
- States / cities
- Torrance, California • Washington D.C., District of Columbia • Gainesville, Florida + 4 more
- Conditions
- Gastrointestinal Diseases
- Interventions
- Self-expandable stent placement via endoscopy
- Procedure
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 23 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2009 – 2016
- U.S. locations
- 1
- States / cities
- Gainesville, Florida
- Conditions
- Abdominal Aortic Aneurysm, Iliac Aneurysm, Internal Iliac Aneurysm
- Interventions
- Endovascular Aneurysm Repair
- Device
- Lead sponsor
- The Cleveland Clinic
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 401 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1998 – 2017
- U.S. locations
- 1
- States / cities
- Cleveland, Ohio
- Conditions
- Restenosis
- Interventions
- Fluency Plus Endovascular Stent Graft, Percutaneous Transluminal Angioplasty only
- Device
- Lead sponsor
- C. R. Bard
- Industry
- Eligibility
- 21 Years and older
- Enrollment
- 275 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2016
- U.S. locations
- 23
- States / cities
- Birmingham, Alabama • Phoenix, Arizona • Sacramento, Arizona + 19 more
- Conditions
- Tricuspid Regurgitation, Tricuspid Regurgitation Functional
- Interventions
- Trillium™
- Device
- Lead sponsor
- Innoventric LTD
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2030
- U.S. locations
- 9
- States / cities
- Thousand Oaks, California • Detroit, Michigan • Rochester, Minnesota + 6 more
- Conditions
- Coronary Artery Disease
- Interventions
- Not listed
- Lead sponsor
- Medstar Health Research Institute
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 984 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2012
- U.S. locations
- 18
- States / cities
- Sacramento, California • Washington D.C., District of Columbia • Springfield, Illinois + 15 more
- Conditions
- Pancreatic Carcinoma
- Interventions
- WallFlex™ Biliary RX Fully Covered/Uncovered Stent System
- Device
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 284 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2021
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Critical Limb Ischemia, Chronic Limb-Threatening Ischemia, Peripheral Arterial Disease
- Interventions
- LimFlow Stent Graft System
- Device
- Lead sponsor
- LimFlow, Inc.
- Industry
- Eligibility
- 18 Years to 95 Years
- Enrollment
- 100 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2027
- U.S. locations
- 30
- States / cities
- La Jolla, California • Palo Alto, California • San Francisco, California + 22 more
- Conditions
- Percutaneous Coronary Intervention, Optical Coherence Tomography, In-stent Coronary Artery Restenosis
- Interventions
- Optical Coherence Tomography
- Device
- Lead sponsor
- Jesse Brown VA Medical Center
- Federal
- Eligibility
- 18 Years and older
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 13
- States / cities
- Birmingham, Alabama • Tucson, Arizona • Long Beach, California + 10 more
- Conditions
- Aortic Aneurysm, Thoracic, Chronic Type B Dissection
- Interventions
- Valiant Mona LSA Thoracic Stent Graft System
- Device
- Lead sponsor
- Medtronic Cardiovascular
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 32 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2024
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Intracranial Aneurysm
- Interventions
- Pipeline Embolization Device (PED), Coil embolization
- Device
- Lead sponsor
- Chestnut Medical Technologies
- Industry
- Eligibility
- 21 Years to 75 Years
- Enrollment
- 13 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2015
- U.S. locations
- 2
- States / cities
- Phoenix, Arizona • Stony Brook, New York
- Conditions
- Thoracic Diseases, Aortic Aneurysm, Aortic Dissection, Thoracic Aortic Aneurysm, Thoracic Aortic Dissection
- Interventions
- Thoraflex Hybrid, RelayPro NBS
- Device
- Lead sponsor
- Vascutek Ltd.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 352 participants
- Timeline
- 2023 – 2036
- U.S. locations
- 18
- States / cities
- Birmingham, Alabama • Los Angeles, California • Aurora, Colorado + 14 more
- Conditions
- Intracranial Aneurysms
- Interventions
- Flow Re-Direction Endoluminal Device (FRED)
- Device
- Lead sponsor
- Microvention-Terumo, Inc.
- Industry
- Eligibility
- 22 Years to 75 Years
- Enrollment
- 145 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2018
- U.S. locations
- 23
- States / cities
- Phoenix, Arizona • Englewood, Colorado • Jacksonville, Florida + 18 more